PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
Analyze DCF forecasts for the company and compare them with competitors.
20.87B
Revenue has increased from the previous period.
6.01%
Revenue growth rate is unchanged from the previous period.
10.87B
EBITDA has increased from the previous period.
52.08%
EBITDA margin is unchanged from the previous period.
9.56B
EBIT has increased from the previous period.
45.81%
EBIT margin is unchanged from the previous period.
1.31B
Depreciation has increased from the previous period.
9.61B
Total cash has increased from the previous period.
46.04%
Cash percentage is unchanged from the previous period.
1.93B
Receivables have increased from the previous period.
9.24%
Receivables percentage is unchanged from the previous period.
3.11B
Inventories have increased from the previous period.
14.89%
Inventory percentage is unchanged from the previous period.
749.49M
Accounts payable has increased from the previous period.
3.59%
Payables percentage is unchanged from the previous period.
-2.78B
Capital expenditure has increased from the previous period.
-13.34%
CapEx percentage is unchanged from the previous period.
8.58%
WACC is unchanged from the previous period.
8.89%
Cost of equity is unchanged from the previous period.
4.26%
Cost of debt is unchanged from the previous period.
0.98
Beta is unchanged from the previous period.
916.00M
Diluted shares outstanding is unchanged from the previous period.
11.22B
Total debt is unchanged from the previous period.
175.82B
Total equity is unchanged from the previous period.
187.04B
Total capital is unchanged from the previous period.
6.00%
Debt weighting is unchanged from the previous period.
94.00%
Equity weighting is unchanged from the previous period.
8.47B
EBIAT has increased from the previous period.
6.75B
UFCF has increased from the previous period.
4.00%
Long-term growth rate is unchanged from the previous period.
172.18B
Terminal value is unchanged from the previous period.
141.73B
Enterprise value is unchanged from the previous period.
8.26B
Net debt is unchanged from the previous period.
133.47B
Equity value is unchanged from the previous period.
145.71
Equity value per share is unchanged from the previous period.
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.73 | 5.46
Analyze analyst forecasts for the company and compare them with competitors.
17.29B
The estimated revenue has increased from the previous period.
9.00B
The estimated EBITDA has increased from the previous period.
5.53
The estimated EPS has increased from the previous period.
5.08B
The estimated net income has increased from the previous period.
7.82B
The estimated EBIT has increased from the previous period.
1.75B
The estimated SG&A expenses have increased from the previous period.
View analysts' price targets and recommendations, and compare them with competitors.
$194.00
Analysts expect the stock price to decrease by 5.82%.
Buy
Positive consensus among analysts.